We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
+13.45%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
+$192M
(+11%)
Cap. Flow
-$8.44M
Cap. Flow
% of AUM
-0.45%
Top 10 Holdings %
Top 10 Hldgs %
11.69%
Holding
260
New
–
Increased
128
Reduced
97
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$11.7M |
| 2 |
UnitedHealth
UNH
|
+$10.7M |
| 3 |
Merck
MRK
|
+$9.96M |
| 4 |
McKesson
MCK
|
+$8.37M |
| 5 |
Comcast
CMCSA
|
+$8.14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$16.4M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$11.5M |
| 3 |
Dentsply Sirona
XRAY
|
+$10.3M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$9.04M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.43% |
| 2 | Healthcare | 19.25% |
| 3 | Financials | 13.87% |
| 4 | Communication Services | 10.49% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
226
Axon Enterprise
AXON
$46.4B
| $362K | 0.02% |
1,400
-2,600
| -65% | -$586K |
|
|
WCN
227
Waste Connections
WCN
$42B
| $299K | 0.02% |
2,000
+900
| +82% | +$124K |
|
|
ANSS
228
DELISTED
Ansys
ANSS
| $254K | 0.01% |
700
-900
| -56% | -$267K |
|
|
DQ
229
Daqo New Energy
DQ
$996M
| $221K | 0.01% |
8,300
-125,400
| -94% | -$3.2M |
|
230
AES
AES
$10.5B
| – | – |
-44,100
| Closed | -$670K |
|
231
Aptiv
APTV
$10.3B
| – | – |
-35,604
| Closed | -$3.51M |
|
232
Aramark
ARMK
$14.7B
| – | – |
-94,319
| Closed | -$2.36M |
|
233
BCE
BCE
$21.2B
| – | – |
-200
| Closed | -$10.4K |
|
|
234
Bunge Global
BG
$20.8B
| – | – |
-151,700
| Closed | -$16.4M |
|
235
Chewy
CHWY
$9.63B
| – | – |
-56,100
| Closed | -$1.02M |
|
236
Clarivate
CLVT
$1.16B
| – | – |
-156,200
| Closed | -$1.05M |
|
237
Evergy
EVRG
$19.2B
| – | – |
-125,200
| Closed | -$6.35M |
|
238
Futu Holdings
FUTU
$15.3B
| – | – |
-94,600
| Closed | -$5.47M |
|
239
GFL Environmental
GFL
$14.9B
| – | – |
-17,100
| Closed | -$738K |
|
240
General Motors
GM
$76.8B
| – | – |
-61,500
| Closed | -$2.03M |
|
241
Healthcare Realty
HR
$6.84B
| – | – |
-405,200
| Closed | -$6.19M |
|
242
IDEX
IEX
$17.3B
| – | – |
-800
| Closed | -$166K |
|
243
Invesco
IVZ
$13.9B
| – | – |
-229,500
| Closed | -$3.33M |
|
244
Lufax Holding
LU
$1.3B
| – | – |
-512,150
| Closed | -$2.17M |
|
245
MINISO
MNSO
$3.75B
| – | – |
-214,300
| Closed | -$5.55M |
|
246
The Mosaic Company
MOS
$7.33B
| – | – |
-190,000
| Closed | -$6.76M |
|
247
Vail Resorts
MTN
$5.3B
| – | – |
-200
| Closed | -$44.4K |
|
248
Nutrien
NTR
$30.7B
| – | – |
-1,000
| Closed | -$83.9K |
|
249
Insulet
PODD
$9.79B
| – | – |
-2,400
| Closed | -$383K |
|
250
Sea Limited
SE
$69.5B
| – | – |
-10,000
| Closed | -$440K |
|
Similar funds
NW
GGHC
FT
DM
GRQ
PCM
IC
NB
Andra AP-fonden's Q4 2023 Portfolio in Review
As of Q4 2023, Andra AP-fonden held 260 positions worth $1.89B, up 11% from $1.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Andra AP-fonden's Q4 2023 filing shows 128 increased, 97 reduced and 31 closed positions. The largest sale was Bunge Global, an estimated $16.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden added most to AbbVie in Q4 2023, an estimated $11.7M increase.
- Andra AP-fonden's biggest Q4 2023 reduction was HP, cutting an estimated $5.37M.
- Andra AP-fonden fully exited Bunge Global in Q4 2023, selling an estimated $16.4M.
- Andra AP-fonden's ten largest holdings make up 12% of its $1.89B portfolio in Q4 2023.
- Andra AP-fonden opened 0 new positions and closed 31 in Q4 2023.
- Andra AP-fonden's portfolio value rose 11% quarter-over-quarter to $1.89B.
Based on Andra AP-fonden's 13F filing for Q4 2023, filed 15 Feb 2024.